Related Experiment Video

Updated: Jun 26, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastoma

John M Maris1

  • 1Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4318, USA. maris@chop.edu

Cancer Cell
|December 30, 2008
PubMed

Insights

Aurora A kinase regulates cell division and interacts with the MYCN oncogene in neuroblastoma. This interaction protects MYCN from degradation, highlighting Aurora A as a potential therapeutic target for cancer.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Aurora A is a crucial mitotic kinase regulating the G2/M cell cycle checkpoint.
  • MYCN is a potent oncogene frequently amplified in human neuroblastoma, driving tumor progression.

Purpose of the Study:

  • To investigate the functional relationship between Aurora A kinase and the MYCN oncogene in neuroblastoma.
  • To elucidate the mechanism by which Aurora A influences MYCN stability.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Western blotting to assess protein levels and degradation.
  • Cellular localization studies.

Main Results:

  • Aurora A directly interacts with MYCN in neuroblastoma cells.
  • This interaction sequesters MYCN, preventing its targeted proteolytic degradation.
  • Elevated Aurora A levels correlate with increased MYCN stability.

Conclusions:

  • Aurora A plays a novel role in stabilizing the MYCN oncogene.
  • The Aurora A-MYCN interaction presents a new therapeutic vulnerability in MYCN-driven neuroblastoma.
  • Targeting Aurora A may offer a strategy to reduce oncogenic MYCN levels.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...